|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2011-8-19
|
|
pubmed:abstractText |
Women aged ? 35 years with breast cancer have a poor prognosis, but their prognostic factors have not been clearly defined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Genetic Markers,
http://linkedlifedata.com/resource/pubmed/chemical/HER2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/PIK3CA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1472-4146
|
|
pubmed:author |
pubmed-author:ChangDwan-YingDY,
pubmed-author:ChangKing-JenKJ,
pubmed-author:ChengAnn-LiiAL,
pubmed-author:HuangChiun-ShengCS,
pubmed-author:KuoKuan-TingKT,
pubmed-author:KuoWen-HungWH,
pubmed-author:LinChing-HungCH,
pubmed-author:LinPo-HanPH,
pubmed-author:LuYen-ShenYS,
pubmed-author:WangChung-ChiehCC,
pubmed-author:YouSan-LinSL
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
781-7
|
|
pubmed:meshHeading |
pubmed-meshheading:21642658-Adult,
pubmed-meshheading:21642658-Age Factors,
pubmed-meshheading:21642658-Breast Neoplasms,
pubmed-meshheading:21642658-DNA, Neoplasm,
pubmed-meshheading:21642658-DNA Mutational Analysis,
pubmed-meshheading:21642658-Disease-Free Survival,
pubmed-meshheading:21642658-Female,
pubmed-meshheading:21642658-Genes, p53,
pubmed-meshheading:21642658-Genetic Markers,
pubmed-meshheading:21642658-Humans,
pubmed-meshheading:21642658-In Situ Hybridization, Fluorescence,
pubmed-meshheading:21642658-Ki-67 Antigen,
pubmed-meshheading:21642658-Neoplasm Staging,
pubmed-meshheading:21642658-Phosphatidylinositol 3-Kinases,
pubmed-meshheading:21642658-Prognosis,
pubmed-meshheading:21642658-Receptor, erbB-2,
pubmed-meshheading:21642658-Survival Rate,
pubmed-meshheading:21642658-Taiwan,
pubmed-meshheading:21642658-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients?
|
|
pubmed:affiliation |
Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
